Study Stopped
Study terminated by sponsor
A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula
1 other identifier
interventional
1
1 country
1
Brief Summary
This clinical trial will evaluate the safety and efficacy of the Strattice-LIFT procedure to treat anal fistulas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for early_phase_1
Started Sep 2014
Typical duration for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 17, 2015
CompletedFirst Posted
Study publicly available on registry
April 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedSeptember 14, 2021
September 1, 2021
2.9 years
April 17, 2015
September 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Healing of the anal fistula
Healing is defined as the combination of patient reported lack of drainage and surgeon reported closure of the external opening
6 months
Secondary Outcomes (3)
Healing of the anal fistula
1 year
Postoperative Pain
1 year
Complications
1 year
Study Arms (1)
Strattice-LIFT
EXPERIMENTALInterventions
Patients undergoing surgery for transsphincteric anal fistulas will undergo the Strattice-LIFT procedure. A standard LIFT procedure will be performed with the addition of Strattice placed into the intersphincteric space.
Eligibility Criteria
You may qualify if:
- Subject is 22 years of age or older
- Subject is willing to comply with study related procedures
- Subject is not pregnant
- Subject has a transsphincteric fistula
- Subject is medically fit to undergo LIFT
- Subject has a draining seton for a minimum of 6 weeks
You may not qualify if:
- Crohn's disease
- Pelvic radiation treatment
- Known or suspected HIV/AIDS
- Known sensitivity to pork products
- Abscess or fistula etiology other than cryptoglandular
- Abdominal malignancies
- Patients with \<1 year life expectancy
- History of smoking
- Known anorectal dysfunction (fecal incontinence)
- Chronic use of steroids or other agents which may affect wound healing
- ASA ≥ 2
- Unable to consent to study
- Unable to complete 1 year follow up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2015
First Posted
April 22, 2015
Study Start
September 1, 2014
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
September 14, 2021
Record last verified: 2021-09